SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-20-270350
Filing Date
2020-10-15
Accepted
2020-10-15 17:16:28
Documents
2
Group Members
VERSANT VENTURES VI GP, L.P.VERSANT VENTURES VI GP-GP, LLCVERSANT VENTURES VII GP, L.P.VERSANT VENTURES VII GP-GP, LLCVERSANT VOYAGEURS I GP COVERSANT VOYAGEURS I GP, L.P.VERSANT VOYAGEURS I PARALLEL, L.P.VERSANT VOYAGEURS I, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D d52779dsc13d.htm SC 13D 178596
2 EX-99.1 d52779dex991.htm EX-99.1 11989
  Complete submission text file 0001193125-20-270350.txt   192494
Mailing Address 740 HEINZ AVENUE BERKELEY CA 94710
Business Address 740 HEINZ AVENUE BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Subject) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88812 | Film No.: 201242115
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 415-801-8100
Versant Venture Capital VII, L.P. (Filed by) CIK: 0001750266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D